Cargando…
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study
BACKGROUND: In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it...
Autores principales: | Mwendera, Chikondi, de Jager, Christiaan, Longwe, Herbert, Phiri, Kamija, Hongoro, Charles, Mutero, Clifford M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888534/ https://www.ncbi.nlm.nih.gov/pubmed/27246503 http://dx.doi.org/10.1186/s12961-016-0108-1 |
Ejemplares similares
-
Development of a framework to improve the utilisation of malaria research for policy development in Malawi
por: Mwendera, Chikondi, et al.
Publicado: (2017) -
Facilitating factors and barriers to malaria research utilization for policy development in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2016) -
Challenges to the implementation of malaria policies in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2019) -
Malaria research in Malawi from 1984 to 2016: a literature review and bibliometric analysis
por: Mwendera, Chikondi A., et al.
Publicado: (2017) -
Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2017)